Risk-reducing salpingo-oophorectomy for BRCA mutation carriers.
作者信息
Haldar Krishnayan, Crawford Robin
出版信息
Maturitas. 2010 Nov;67(3):290. doi: 10.1016/j.maturitas.2010.08.009. Epub 2010 Sep 24.
Abstract
摘要
相似文献
1
Risk-reducing salpingo-oophorectomy for BRCA mutation carriers.为携带BRCA突变者进行的降低风险的输卵管卵巢切除术。
Maturitas. 2010 Nov;67(3):290. doi: 10.1016/j.maturitas.2010.08.009. Epub 2010 Sep 24.
2
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.对携带BRCA1或BRCA2基因突变的女性进行降低风险的输卵管卵巢切除术。
N Engl J Med. 2002 May 23;346(21):1609-15. doi: 10.1056/NEJMoa020119. Epub 2002 May 20.
3
Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.BRCA1/2 突变携带者中预防性输卵管卵巢切除术的短期手术结果和安全性。
Maturitas. 2010 Jul;66(3):310-4. doi: 10.1016/j.maturitas.2010.03.018. Epub 2010 Apr 21.
4
Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.携带BRCA1-2基因突变者的口服避孕药、输卵管卵巢切除术及激素替代疗法
Maturitas. 2008 Jun 20;60(2):71-7. doi: 10.1016/j.maturitas.2008.03.004. Epub 2008 May 9.
5
Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations.
N Engl J Med. 2002 May 23;346(21):1660-2. doi: 10.1056/NEJMed020044. Epub 2002 May 20.
6
CA125 screening after risk-reducing salpingo-oophorectomy: are the titers too high, or is it all just too much?降低风险的输卵管卵巢切除术后的CA125筛查：是检测值过高，还是这一切都太过了？
Menopause. 2011 Feb;18(2):123-4. doi: 10.1097/gme.0b013e31820246da.
7
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者的预防性输卵管卵巢切除术。
Arch Gynecol Obstet. 2011 Mar;283(3):623-7. doi: 10.1007/s00404-010-1476-3. Epub 2010 Apr 29.
8
Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.BRCA1/2 突变携带者行预防性输卵管卵巢切除术的生存者监测：随访
Gynecol Oncol. 2011 Aug;122(2):339-43. doi: 10.1016/j.ygyno.2011.04.004. Epub 2011 Apr 30.
9
Oophorectomy in carriers of BRCA mutations.
N Engl J Med. 2002 Sep 26;347(13):1037-40; author reply 1037-40.
10
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.接受降低风险的输卵管卵巢切除术的女性隐匿性肿瘤的预测因素。
Am J Obstet Gynecol. 2006 Jun;194(6):1702-9. doi: 10.1016/j.ajog.2006.03.006.
引用本文的文献
1
HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases.携带BRCA1基因突变的患者在接受预防性手术时以及其他良性和恶性妇科疾病患者的血清HE4水平
Dis Markers. 2017;2017:9792756. doi: 10.1155/2017/9792756. Epub 2017 Jan 15.
Zotero 插件